Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Summit Therapeu ADR
(NQ:
SMMT
)
31.93
+4.52 (+16.49%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
24,434,876
Open
27.50
Bid (Size)
33.00 (40)
Ask (Size)
33.05 (3)
Prev. Close
27.41
Today's Range
27.41 - 33.60
52wk Range
1.640 - 33.60
Shares Outstanding
97,381,774
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Up More Than 500% in 2024. Can Instil Bio Keep Rocketing Higher?
Today 4:56 EDT
A candidate that Instil Bio in-licensed this August is similar to a candidate that recently outperformed the world's top-selling cancer therapy.
Via
The Motley Fool
Here's How Much $100 Invested In Summit Therapeutics 5 Years Ago Would Be Worth Today
September 13, 2024
Via
Benzinga
Performance
YTD
+1109.47%
+1109.47%
1 Month
+169.00%
+169.00%
3 Month
+304.18%
+304.18%
6 Month
+675.94%
+675.94%
1 Year
+1607.49%
+1607.49%
More News
Read More
Why Summit Therapeutics Skyrocketed 123% This Week
September 13, 2024
Via
The Motley Fool
Why Summit Therapeutics Stock Is Soaring Again Today
September 12, 2024
Via
The Motley Fool
Signet Jewelers Posts Better-Than-Expected Earnings, Joins NETGEAR, Lovesac And Other Big Stocks Moving Higher On Thursday
September 12, 2024
Via
Benzinga
Summit Therapeutics Options Trading: A Deep Dive into Market Sentiment
September 11, 2024
Via
Benzinga
Summit Therapeutics, With 85% Gain This Week, Rockets Again On $235 Million Sale
September 12, 2024
Via
Investor's Business Daily
Summit Therapeutics Surges on Trial Results: Time to Buy?
September 12, 2024
Via
MarketBeat
Why Summit Therapeutics (SMMT) Stock Is Rising Today
September 12, 2024
Via
Benzinga
Summit Therapeutics Raises $235 Million
September 12, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Is Summit Therapeutics a Buy Now?
September 10, 2024
Via
The Motley Fool
Why Summit Therapeutics Rocketed Over 60% Today
September 09, 2024
Via
The Motley Fool
Terns Pharmaceuticals, Boeing, Tesla And Other Big Stocks Moving Higher On Monday
September 09, 2024
Via
Benzinga
Starbucks To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Monday
September 09, 2024
Via
Benzinga
Biotech Stocks: Lung Cancer Treatment Outflanks Merck's Keytruda
September 09, 2024
Via
Investor's Business Daily
Summit Therapeutics' Lung Cancer Candidate Surpasses Merck's Multi-Billion Dollar Keytruda, Cuts Risk Of Disease Or Death By Half
September 09, 2024
Via
Benzinga
Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
September 09, 2024
Via
Benzinga
Ivonescimab Monotherapy Reduced the Risk of Disease Progression or Death by 49% Compared to Pembrolizumab Monotherapy in First-Line Treatment of Patients with PD-L1 Positive Advanced NSCLC in China
September 08, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 06, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
HARMONi-2, Featuring Ivonescimab Monotherapy vs. Pembrolizumab Monotherapy, to be Showcased in Presidential Symposium at WCLC 2024
August 12, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 09, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
SMMT Stock Earnings: Summit Therapeutics Beats EPS for Q2 2024
August 06, 2024
Via
InvestorPlace
Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2024
August 06, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Summit Therapeutics to Host Second Quarter 2024 Financial Results & Operational Progress Call on August 6, 2024
July 29, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
July 26, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.